As competition for eligible participants intensifies and regulatory expectations evolve, sponsors face growing challenges in designing and executing metabolic clinical trials. This insight brief explores the operational differences between Type 2 Diabetes Mellitus (T2DM) and obesity studies, including patient selection, recruitment, retention, and data quality considerations.

Read the insight brief in full to distill how data-driven feasibility assessments, real-world evidence, site intelligence, and patient-centered trial strategies can help improve enrollment, reduce attrition, and support successful global development programs.